Impact of sleeve gastrectomy on weight loss, glucose homeostasis, and comorbidities in severely obese type 2 diabetic subjects

G Nosso, L Angrisani, G Saldalamacchia, P P Cutolo, M Cotugno, R Lupoli, G Vitolo, B Capaldo, G Nosso, L Angrisani, G Saldalamacchia, P P Cutolo, M Cotugno, R Lupoli, G Vitolo, B Capaldo

Abstract

This study was undertaken to assess medium-term effects of laparoscopic sleeve gastrectomy (LSG) on body weight and glucose homeostasis in severely obese type 2 diabetic (T2DM) subjects. Twenty-five obese T2DM subjects (10 M/15 F, age 45 ± 9 years, BMI 48 ± 8 kg/m(2), M ± SD) underwent evaluation of anthropometric/clinical parameters and glucose homeostasis before, 3 and 9-15 months after LSG. Mean BMI decreased from 48 ± 8 kg/m(2) to 40 ± 9 kg/m(2) (P < .001) at 3 months and 34 ± 6 kg/m(2) (P < .001) at 9-15 months after surgery. Remission of T2DM (fasting plasma glucose < 126 mg/dL and HbA1c < 6.5% in the absence of hypoglycemic treatment) occurred in all patients but one. There was a remarkable reduction in the percentage of patients requiring antihypertensive and hypolipidemic drugs. Our study shows that LSG is effective in producing a significant and sustained weight loss and improving glucose homeostasis in severely obese T2DM patients.

References

    1. Mensah GA, Mokdad AH, Ford E, et al. Obesity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implications. Cardiology Clinics. 2004;22(4):485–504.
    1. Bessesen DH. Update on obesity. Journal of Clinical Endocrinology and Metabolism. 2008;93(6):2027–2034.
    1. Schernthaner G, Morton JM. Bariatric surgery in patients with morbid obesity and type 2 diabetes. Diabetes care. 2008;31(supplement 2):S297–S302.
    1. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. American Journal of Medicine. 2009;122(3):248–256.
    1. Sjöström L, Lindroos A-K, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. The New England Journal of Medicine. 2004;351(26):2683–2693.
    1. Daskalakis M, Weiner RA. Sleeve gastrectomy as a single-stage bariatric operation: indications and limitations. Obesity Facts. 2009;2(1, supplement):8–10.
    1. Vidal J, Ibarzabal A, Romero F, et al. Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obesity Surgery. 2008;18(9):1077–1082.
    1. Miguel GPS, Azevedo JLMC, Gicovate Neto C, Moreira CLCB, Viana EC, Carvalho PS. Glucose homeostasis and weight loss in morbidly obese patients undergoing banded sleeve gastrectomy: a prospective clinical study. Clinics. 2009;64(11):1093–1098.
    1. Shi X, Karmali S, Sharma AM, Birch DW. A review of laparoscopic sleeve gastrectomy for morbid obesity. Obesity Surgery. 2010;20:1171–1177.
    1. National Institutes of Health. Clinical Guidelines on the identification, evaluation and treatment of overweight and obesity in adults. The evidence report. Obesity Research . 1998;6(supplement 2):51S–209S.
    1. Rosenthal R, Li X, Samuel S, Martinez P, Zheng C. Effect of sleeve gastrectomy on patients with diabetes mellitus. Surgery for Obesity and Related Diseases. 2009;5(4):429–434.
    1. Abbatini F, Rizzello M, Casella G, et al. Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surgical Endoscopy. 2009;24(5):1005–1010.
    1. Rizzello M, Abbatini F, Casella G, et al. Early postoperative insulin-resistance changes after sleeve gastrectomy. Obesity Surgery. 2010;20(1):50–55.
    1. Thaler JP, Cummings DE. Minireview: hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology. 2009;150(6):2518–2525.
    1. Beckman LM, Beckman TR, Earthman CP. Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass procedure: a review. Journal of the American Dietetic Association. 2010;110(4):571–584.
    1. Vidal J, Nicolau J, Romero F, et al. Long-term effects of roux-en-y gastric bypass surgery on plasma glucagon-like peptide-1 and islet function in morbidly obese subjects. Journal of Clinical Endocrinology and Metabolism. 2009;94(3):884–891.
    1. Peterli R, Wölnerhanssen B, Peters T, et al. Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Annals of Surgery. 2009;250(2):234–241.
    1. Koch TR, Finelli FC. Postoperative metabolic and nutritional complications of bariatric surgery. Gastroenterology Clinics of North America. 2010;39(1):109–124.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever